Essential Oil Blend for Immune Support

(OGS Trial)

NS
Overseen ByNicole Stevens, PhD
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: dōTERRA International

What You Need to Know Before You Apply

What is the purpose of this trial?

This randomized, double-blind, placebo-controlled clinical trial will evaluate the safety and efficacy of an essential oil-based product system for immune support in healthy adolescents and adults aged 18-45 years. Participants will be randomized to receive aromatic, topical, internal, or combined use of the investigational product or matching placebo for 30 days.

The aromatic intervention consists of overnight diffusion, the topical intervention consists of diluted application to specified areas prior to bedtime, and the internal intervention consists of oral capsule administration twice daily. Study visits will occur at baseline and at the end of the 30-day intervention period.

Primary outcomes include changes in immune-related biomarkers, including complete blood count, comprehensive metabolic panel, salivary immunoglobulin A (IgA), and inflammatory cytokines (IL-6, TNF-α, IL-10). Epigenetic markers will also be evaluated. Secondary outcomes include validated subjective assessments of immune status and overall well-being, as well as evaluation of safety and tolerability.

The study includes an adaptive design with interim analysis to assess enrollment and study continuation parameters.

Who Is on the Research Team?

NS

Nicole Stevens, PhD

Principal Investigator

DoTERRA International LLC.

Are You a Good Fit for This Trial?

This trial is for healthy men and women aged 18-45 who can attend study visits, follow instructions, and avoid using essential oils outside the study. People with allergies to essential oils, certain health conditions (like asthma or heart disease), tobacco users, pregnant or breastfeeding women, and those recently using essential oils without a washout period cannot join.

Inclusion Criteria

Willing to refrain from use of essential oils (topical, aromatic, or internal) outside of the study during the study period
I am a healthy adult between 18 and 45 years old.
Able to read, write, and understand English
See 3 more

Exclusion Criteria

Use of recreational drugs
Known allergy or hypersensitivity to essential oils or components of placebo preparation
Current use of tobacco products including smoking, vaping, or chewing tobacco
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the investigational essential oil-based product system or placebo for 30 days through aromatic, topical, internal, or combined use

4 weeks
2 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Essential Oil Blend

Trial Overview

The study tests an essential oil blend used in different ways—aromatic (diffused overnight), topical (applied to skin before bed), internal (oral capsules twice daily), or combinations—compared to a placebo. Participants are randomly assigned treatments for 30 days in a double-blind design.

How Is the Trial Designed?

8

Treatment groups

Experimental Treatment

Placebo Group

Group I: Topical - ActiveExperimental Treatment1 Intervention
Group II: Internal - ActiveExperimental Treatment1 Intervention
Group III: Combined - ActiveExperimental Treatment1 Intervention
Group IV: Aromatic - ActiveExperimental Treatment1 Intervention
Group V: Aromatic - PlaceboPlacebo Group1 Intervention
Group VI: Topical - PlaceboPlacebo Group1 Intervention
Group VII: Internal - PlaceboPlacebo Group1 Intervention
Group VIII: Combined - PlaceboPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

dōTERRA International

Lead Sponsor

Trials
7
Recruited
580+